Contribution of MHC class I region to genetic susceptibility for giant cell arteritis

Rheumatology

Volumn 46, Issue 3, 2007, Pages 431-434

  Gonzalez Gay, M A ^a   Rueda, B ^b   Vilchez, J R ^c   Lopez Nevot, M A ^c   Robledo, G ^b   Ruiz, M P ^b   Fernandez O ^d   Garcia Porrua, C ^a   Gonzalez Escribano, M F ^d   Martín, Javier ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Genetics; Giant cell (temporal) arteritis; HLA B; HLA DRB1; MICA; Susceptibility

Indexed keywords

HLA B ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED GENE A PROTEIN; PROTEIN MICA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPAIN;

AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; TEMPORAL ARTERITIS;

EID: 33847346000     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel324     Document Type: Article

References (26)

1. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27:729-49.
2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
3. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003;33:38-48.
4. Weyand CM, Hunder NNH, Hicock KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
5. Jacobsen S, Baslund B, Madsen HO, Tvede N, Svejgaard A, Garred P. Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J Rheumatol 2002;29:2148-53.
6. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998;25:2140-5.
7. Weyand CM, Goronzy JJ. Giant cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;139:505-15.
8. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994;91:6259-63.
9. Bahram S, Mizuki N, Inoko H, Spies T. Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics 1996;44:80-1.
10. Ota M, Katsuyama Y, Mizuki N et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhastan, Iranian Saudi Arabian, Greek and Italian. Tissue Antigens 1997;49:448-54.
11. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
12. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: Two different but often overlapping conditions. Semin Arthritis Rheum 2004;33:289-93.
13. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005;84:269-76.
14. Svejaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994;43:18-27.
15. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-21.
16. Gambelunghe G, Gerli R, Bocci EB, Del Sindaco P, Ghaderi M, Sanjeevi CB. Contribution of MHC class I chain-related gene A (MICA) polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology 2005;44:287-92.
17. Pedron B, Yakouben K, Adjaoud D et al. Listing of common HLA alleles and haplotypes based on the study of 356 families residing in the Paris, France, area: Implications for unrelated hematopoietic stem cell donor selection. Hum Immunol 2005;66:721-31.
18. Middleton D, Williams F, Hamill MA, Meenagh A. Frequency of HLA-B alleles in a Caucasoid population determined by a two-stage PCR-SSOP typing strategy. Hum Immunol 2000;61:1285-97.
19. Mizuki N, Ota M, Kimura M et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci USA 1997;94:1298-303.
20. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota - Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:374-80.
21. Hoffman G. Large-vessel vasculitis. Unresolved issues. Arthritis Rheum 2003;48:2406-2414.
22. Suemizu H, Radosavljevic M, Kimura M et al. A basolateral sorting motif in the MICA cytoplasmic tail. Proc Natl Acad Sci USA 2002;99:2971-6.
23. Martinez A, Fernandez-Arquero M, Balsa A et al. Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis Rheum 2001;44:1261-5.
24. Gambelunghe G, Ghaderi M, Tortoioli C et al. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J Clin Endocrinol Metab 2001;86:3754-60.
25. Gupta M, Nikita-Zake L, Zarghami M et al. Association between the transmembrane region polymorphism of MHC class I chain related gene-A and type 1 diabetes in Sweden. Hum Immunol 2003;64:553-61.
26. Van Autreve JE, Koeleman BP, Quartier E et al. MICA is associated with type I diabetes in the Belgian population, independent of HLA-DQ. Hum Immunol 2006;67:94-101.